Merck’s Springworks Therapeutics secures landmark approval from the European Commission for Ezmekly (mirdametinib) for treating symptomatic, inoperable plexiform neurofibromas...

The European Commission has granted conditional marketing authorization to Springworks Therapeutics’ Ezmekly (mirdametinib) for treating symptomatic, inoperable plexiform neurofibromas...

Procept Biorobotics has secured a significant win with the assignment of a Category I CPT code for its Aquablation...

Longevity Health Holdings (Nasdaq: XAGE), a company focused on longevity and healthy aging, is merging with True Health Inc....

Sanara MedTech has launched a pilot program for its Tissue Health Plus (THP) wound care platform, targeting value-based care...

Branded Legacy Inc. is undergoing a rapid transformation, shifting its focus from plant-based wellness and cannabis beverages to the...

Ttam Research Institute, a non-profit led by Anne Wojcicki, has finalized its acquisition of 23andMe’s personal genome service and...

Journey Medical Corporation has significantly expanded payer coverage for its recently launched rosacea treatment, emrosi™ (minocycline hydrochloride modified-release capsules)....

Salarius Pharmaceuticals has received another extension from Nasdaq, pushing the deadline for regaining compliance with minimum bid price and...